New research finds that metabolic and bariatric surgery is more effective for long-term weight loss than lifestyle changes ...
Tirzepatide, the main ingredient for Eli Lilly's Mounjaro and Zepbound, omitted the presence of metabolic dysfunction-associated steatohepatitis in a phase 2 study, the drugmaker said June 8. The ...
Folks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional requirements ... Related Study: Weight-loss drugs may reduce the risk of acute pancreatitis recurrence Popular ...
Evidence that weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound can cut heart disease risk, treat sleep ...
Eli Lilly (LLY) is riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall ... the recent ...
Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its popular weight-loss and diabetes treatments, Zepbound and Mounjaro.
Eli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or ...
By elevating your head or changing your sleeping position, you may be able to reduce some symptoms of sleep apnea. That said, it’s important to talk with your doctor if you consistently feel ...
A new study has found they also reduce aggression. Researchers say the safe, common supplements should be used everywhere from the playground to the prison system. Overt acts of aggression include ...
Several doses of Wegovy, Zepbound, and Mounjaro are all currently in limited supply due to increased demand, according to the U.S Food and Drug Administration (FDA). Today, the telehealth platform ...
which found that teens ate less produce after a poor night’s sleep. Still, it has its limitations. Since the data came from self-reported questionnaires, it’s not guaranteed that all the ...